Actively Recruiting
Quality of Life and Predictive Factors in Diabetic Patients With Chronic Wound-Free Charcot Foot A Prospective Multicenter Cohort Study in France
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2026-10-23
150
Participants Needed
17
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Charcot foot is a complication of diabetes characterized by progressive damage to bones, soft tissues, and tendons, leading to dislocation in the ankle and foot. It is often poorly understood and underdiagnosed due to non-specific signs. This study follows a group of patients with chronic Charcot foot in France to examine changes in quality of life over two years and identify factors that predict worse outcomes within this population. Participants will be observed without any experimental treatment. They will complete various questionnaires including SF-36, FAAM-F, PHQ-9, PHQ-2, and a simplified EPICES score to assess quality of life, foot and ankle function, and mental health. The study will also track radiologic changes in foot deformities and monitor diabetes complications and comorbidities at baseline, 12 months, and 24 months. During the two-year follow-up, participants will undergo evaluations including quality of life and functional questionnaires at the start, one year, and two years. Imaging studies will assess foot bone and joint deformities, and medical records will be reviewed for diabetes-related complications, hospitalizations, wounds, infections, amputations, and psychological status. The study aims to better understand the factors impacting quality of life and foot health in chronic Charcot foot patients over time.
CONDITIONS
Brief Title
Factors Associated With an Evolution in the Quality of Life of Diabetic Patients With Chronic, Wound-free Charcot Foot
Research Team
S
Sophie Schuldiner, Dr.
A
Anissa MEGZARI
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here